• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多阶段致癌作用中的异质性与混合物建模

Heterogeneity in multistage carcinogenesis and mixture modeling.

作者信息

Gsteiger Sandro, Morgenthaler Stephan

机构信息

Institute of Mathematics, Swiss Federal Institute of Technology, Lausanne, Switzerland.

出版信息

Theor Biol Med Model. 2008 Jul 21;5:13. doi: 10.1186/1742-4682-5-13.

DOI:10.1186/1742-4682-5-13
PMID:18644142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2515834/
Abstract

Carcinogenesis is commonly described as a multistage process, in which stem cells are transformed into cancer cells via a series of mutations. In this article, we consider extensions of the multistage carcinogenesis model by mixture modeling. This approach allows us to describe population heterogeneity in a biologically meaningful way. We focus on finite mixture models, for which we prove identifiability. These models are applied to human lung cancer data from several birth cohorts. Maximum likelihood estimation does not perform well in this application due to the heavy censoring in our data. We thus use analytic graduation instead. Very good fits are achieved for models that combine a small high risk group with a large group that is quasi immune.

摘要

癌症发生通常被描述为一个多阶段过程,在此过程中干细胞通过一系列突变转化为癌细胞。在本文中,我们考虑通过混合建模对多阶段癌症发生模型进行扩展。这种方法使我们能够以生物学上有意义的方式描述群体异质性。我们专注于有限混合模型,并证明了其可识别性。这些模型被应用于来自几个出生队列的人类肺癌数据。由于我们的数据存在严重删失,最大似然估计在该应用中表现不佳。因此我们改用解析修匀法。对于将一个小的高风险组与一个几乎免疫的大组相结合的模型,拟合效果非常好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/dfd9f1c5f1de/1742-4682-5-13-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/35bdd1e73f95/1742-4682-5-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/c8840a40ba31/1742-4682-5-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/12e0c89ba56a/1742-4682-5-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/1b6caa1d52c1/1742-4682-5-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/9ea4d306634e/1742-4682-5-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/1a17f7b86eeb/1742-4682-5-13-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/ca3693f167fa/1742-4682-5-13-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/be85d179d5ed/1742-4682-5-13-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/501ef5a65eca/1742-4682-5-13-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/485467179319/1742-4682-5-13-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/dfd9f1c5f1de/1742-4682-5-13-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/35bdd1e73f95/1742-4682-5-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/c8840a40ba31/1742-4682-5-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/12e0c89ba56a/1742-4682-5-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/1b6caa1d52c1/1742-4682-5-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/9ea4d306634e/1742-4682-5-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/1a17f7b86eeb/1742-4682-5-13-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/ca3693f167fa/1742-4682-5-13-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/be85d179d5ed/1742-4682-5-13-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/501ef5a65eca/1742-4682-5-13-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/485467179319/1742-4682-5-13-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1862/2515834/dfd9f1c5f1de/1742-4682-5-13-11.jpg

相似文献

1
Heterogeneity in multistage carcinogenesis and mixture modeling.多阶段致癌作用中的异质性与混合物建模
Theor Biol Med Model. 2008 Jul 21;5:13. doi: 10.1186/1742-4682-5-13.
2
Estimating age, period and cohort effects using the multistage model for cancer.
Stat Med. 1994 Jan 15;13(1):23-41. doi: 10.1002/sim.4780130105.
3
Multistage carcinogenesis and lung cancer mortality in three cohorts.三个队列中的多阶段致癌作用与肺癌死亡率
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1171-81. doi: 10.1158/1055-9965.EPI-04-0756.
4
Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis.癌症发生多阶段克隆扩增(MSCE)模型中的对称性、可识别性和预测不确定性
Risk Anal. 2007 Dec;27(6):1441-53. doi: 10.1111/j.1539-6924.2007.00980.x.
5
Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis.基于癌症发病率数据的多阶段克隆扩增模型的参数估计:一项实际可识别性分析。
PLoS Comput Biol. 2017 Mar 13;13(3):e1005431. doi: 10.1371/journal.pcbi.1005431. eCollection 2017 Mar.
6
Multistage models of carcinogenesis: an approximation for the size and number distribution of late-stage clones.
Risk Anal. 1994 Dec;14(6):1039-48. doi: 10.1111/j.1539-6924.1994.tb00074.x.
7
The Armitage-Doll multistage model of carcinogenesis.
Stat Med. 1990 Jun;9(6):677-9. doi: 10.1002/sim.4780090614.
8
Semiparametric accelerated failure time cure rate mixture models with competing risks.具有竞争风险的半参数加速失效时间治愈率混合模型
Stat Med. 2018 Jan 15;37(1):48-59. doi: 10.1002/sim.7508. Epub 2017 Oct 6.
9
Multistage carcinogenesis and the fraction at risk.多阶段致癌作用与风险比例
J Math Biol. 2004 Nov;49(5):455-67. doi: 10.1007/s00285-004-0271-9. Epub 2004 Apr 23.
10
Incorporating additional biological phenomena into two-stage cancer models.将额外的生物学现象纳入两阶段癌症模型。
Prog Clin Biol Res. 1994;387:237-60.

引用本文的文献

1
Effect of census-based correction of population figures on mortality rates in Germany.基于人口普查的人口数据校正对德国死亡率的影响。
Popul Health Metr. 2025 Jan 28;23(1):1. doi: 10.1186/s12963-025-00361-5.
2
Invariant Characteristics of Carcinogenesis.癌症发生的不变特征。
PLoS One. 2015 Oct 14;10(10):e0140405. doi: 10.1371/journal.pone.0140405. eCollection 2015.
3
Heuristic modeling of carcinogenesis for the population with dichotomous susceptibility to cancer: a pancreatic cancer example.对癌症具有二分易感性人群的致癌作用启发式建模:以胰腺癌为例。

本文引用的文献

1
Multistage carcinogenesis and the fraction at risk.多阶段致癌作用与风险比例
J Math Biol. 2004 Nov;49(5):455-67. doi: 10.1007/s00285-004-0271-9. Epub 2004 Apr 23.
2
Frailty modelling of testicular cancer incidence using Scandinavian data.利用斯堪的纳维亚数据对睾丸癌发病率进行衰弱建模。
Biostatistics. 2004 Jan;5(1):1-14. doi: 10.1093/biostatistics/5.1.1.
3
The age distribution of cancer and a multi-stage theory of carcinogenesis.癌症的年龄分布与致癌作用的多阶段理论。
PLoS One. 2014 Jun 16;9(6):e100087. doi: 10.1371/journal.pone.0100087. eCollection 2014.
4
Basic equations and computing procedures for frailty modeling of carcinogenesis: application to pancreatic cancer data.癌症发生脆弱性建模的基本方程和计算程序:应用于胰腺癌数据
Cancer Inform. 2013;12:67-81. doi: 10.4137/CIN.S8063. Epub 2013 Feb 18.
5
What role for biologically based dose-response models in estimating low-dose risk?在估计低剂量风险方面,基于生物学的剂量-反应模型有什么作用?
Environ Health Perspect. 2010 May;118(5):585-8. doi: 10.1289/ehp.0901249. Epub 2010 Jan 4.
Br J Cancer. 1954 Mar;8(1):1-12. doi: 10.1038/bjc.1954.1.
4
A new theory on cancer-inducing mechanism.一种关于癌症诱发机制的新理论。
Br J Cancer. 1953 Mar;7(1):68-72. doi: 10.1038/bjc.1953.8.
5
Multistage carcinogenesis and the incidence of colorectal cancer.多阶段致癌作用与结直肠癌的发病率
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15095-100. doi: 10.1073/pnas.222118199. Epub 2002 Nov 1.
6
Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.结肠癌的人群风险和生理速率参数。将明确的致癌模型与美国公共卫生记录相结合。
Mutat Res. 2000 Jan 17;447(1):73-116. doi: 10.1016/s0027-5107(99)00201-8.
7
Analyzing incidence of testis cancer by means of a frailty model.通过脆弱模型分析睾丸癌的发病率。
Cancer Causes Control. 1999 Aug;10(4):285-92. doi: 10.1023/a:1008916718152.
8
Carcinogenesis models for risk assessment.用于风险评估的致癌作用模型。
Stat Methods Med Res. 1997 Dec;6(4):317-40. doi: 10.1177/096228029700600403.
9
Some properties of the hazard function of the two-mutation clonal expansion model.双突变克隆扩增模型的风险函数的一些性质。
Risk Anal. 1997 Jun;17(3):391-9. doi: 10.1111/j.1539-6924.1997.tb00878.x.
10
The two-stage model of carcinogenesis: overcoming the nonidentifiability dilemma.
Risk Anal. 1997 Jun;17(3):367-74. doi: 10.1111/j.1539-6924.1997.tb00875.x.